BLOG: Today's announcement about mpMRI scans before a biopsy is a game-changer for prostate cancer diagnosis. But without Prostate Cancer UK's funding of a pilot project in 2010 thanks to your donations, this ground-breaking research would never have happened, says Dr Ian Le Guillou.
BLOG: We're only 12 months into our ten-year strategy to tame prostate cancer, but that doesn't mean we haven't already made exciting progress. Our resident expert, Dr Ian Le Guillou, gives us his top ten biggest research breakthroughs (in no particular order) from 2016.
A new type of treatment for early-stage prostate cancer, using lasers to target tumours without damaging surrounding tissue, could offer a choice for men to avoid surgery or radiotherapy. But further research is needed to determine which cancers it's most suited to and the long-term side effects.
The Royal College of Surgeons finds 90 per cent of men who had surgery or radiotherapy to cure their prostate cancer on the English NHS rated their care as very good. But Prostate Cancer UK is concerned that over-treatment of men with low-risk localised disease hasn't declined.
A new type of treatment that alternately floods and starves the body of testosterone has shown good early results in men with advanced prostate cancer, according to new findings revealed today.
With the support of the Movember Foundation, we're funding four PhD students in the crucial field of bioinformatics, using big data to help accelerate our understanding and treatment of prostate cancer.
BLOG: While doom-laden reports about chronic underfunding appear daily in the news, the NHS is still committed to transforming cancer treatment in the UK by 2020. So is it all just pie in the sky? Our Policy Manager, Phillip Anderson, doesn't think so, but argues we must get smarter about making our case for investment in prostate cancer if we're going to get the best deal for men.
The Ipswich Town FC cycling team, which has raised £150,000 riding in our Football to Amsterdam event, visit the University of East Anglia to find out how they’re using the money to prove a link between advanced prostate cancer and bacterial infections using urine samples. It’s a topic that brings back sore memories for one of the cycling team’s members, former England captain Terry Butcher.
Following reports in the press yesterday of a US study into androgen deprivation therapy – a commonly used treatment for men with prostate cancer in the UK – Prostate Cancer UK's Dr Iain Le Guilliou investigates whether there's any solid proof behind claims it could double the risk of dementia.
The 2016 Nobel Prize for medicine has been awarded to Japanese scientist Yoshinori Ohsumi for research into how cells' survival mechanism can go wrong, an important area for understanding how cancer develops.